PPARs and Anticancer Therapies

• PPARs and Anticancer Therapies, Michael E. C. Robbins, Christine Linard, and Dipak Panigrahy
  Volume 2010 (2010), Article ID 536415, 2 pages
• Combination PPAR and RXR Agonist Treatment in Melanoma Cells: Functional Importance of S100A2, Joshua P. Klopper, Vibha Sharma, Reid Bissonnette, and Bryan R. Haugen
  Volume 2010 (2010), Article ID 729876, 8 pages
• Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma, Stefanie Meyer, Thomas Vogt, Michael Landthaler, Anna Berand, Albrecht Reichle, Frauke Bataille, Andreas H. Marx, Anne Menz, Arndt Hartmann, Leoni A. Kunz-Schughart, and Peter J. Wild
  Volume 2010 (2010), Article ID 848645, 11 pages
• Role of PPARs in Radiation-Induced Brain Injury, Sriram Ramanan, Weiling Zhao, David R. Riddle, and Mike E. Robbins
  Volume 2010 (2010), Article ID 234975, 12 pages
• PPARs in Irradiation-Induced Gastrointestinal Toxicity, Christine Linard and Maâmar Souidi
  Volume 2010 (2010), Article ID 528327, 12 pages
• PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors, Elisabetta Benedetti, Renato Galzio, Barbara D'Angelo, Maria Paola Cerù, and Annamaria Cimini
  Volume 2010 (2010), Article ID 427401, 9 pages
• Anticancer Role of PPAR Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes, P. J. Simpson-Haidaris, S. J. Pollock, S. Ramon, N. Guo, C. F. Woeller, S. E. Feldon, and R. P. Phipps
  Volume 2010 (2010), Article ID 814609, 36 pages
• Therapeutic Implications of PPAR in Human Osteosarcoma, Eric R. Wagner, Bai-Cheng He, Liang Chen, Guo-Wei Zuo, Wenli Zhang, Qiong Shi, Qing Luo, Xiaoji Luo, Bo Liu, Jinyong Luo, Farbod Rastegar, Connie J. He, Yawen Hu, Barrett Boody, Hue H. Luu, Tong-Chuan He, Zhong-Liang Deng, and Rex C. Haydon
  Volume 2010 (2010), Article ID 956427, 16 pages